Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,210,303 | 2,478,052 | 8,293,305 | 7,497,020 | 4,565,081 |
| Depreciation Amortization | 3,694,801 | 623,893 | 3,051,472 | 3,666,288 | 2,647,159 |
| Accounts receivable | N/A | N/A | -808,363 | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | 172,750 | N/A | N/A |
| Other Working Capital | -700,576 | -1,389,272 | -2,508,167 | -3,112,301 | -2,429,457 |
| Other Operating Activity | -1,062,943 | -175,175 | 2,007,063 | -687,429 | -454,103 |
| Operating Cash Flow | $5,141,585 | $1,537,498 | $10,208,060 | $7,363,578 | $4,328,680 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 198,631 | 8,085 | 142,420 | 14,827 | N/A |
| PPE Investments | -696,550 | -261,415 | -1,745,959 | -1,029,796 | -611,705 |
| Net Acquisitions | -2,446,648 | -1,561,752 | -2,266,845 | -2,268,516 | -1,107,212 |
| Purchase Of Investment | N/A | N/A | N/A | -70,091 | -60,102 |
| Sale Of Investment | N/A | N/A | N/A | 186,010 | 24,041 |
| Purchase Sale Intangibles | -257,683 | -215,600 | -2,007,061 | -1,446,297 | -722,560 |
| Other Investing Activity | -81,869 | -160,353 | -1,711,673 | -1,280,504 | -607,699 |
| Investing Cash Flow | $-3,026,436 | $-1,975,435 | $-5,582,057 | $-4,448,070 | $-2,362,677 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,967,519 | 1,611,610 | 1,430,790 | 742,693 | 136,231 |
| Debt Issued | N/A | N/A | 2,609,707 | 2,667,494 | 2,648,495 |
| Debt Repayment | -1,160,917 | N/A | -1,846,180 | -1,889,756 | -1,881,860 |
| Common Stock Issued | 12,079 | 10,780 | 19,781 | 18,871 | 18,698 |
| Common Stock Repurchased | -850,891 | -439,285 | -1,815,850 | -1,516,387 | -1,079,165 |
| Dividend Paid | -1,838,677 | -866,443 | -3,381,147 | -2,585,272 | -1,693,541 |
| Other Financing Activity | -648,235 | 49,858 | -1,876,511 | -1,250,852 | -170,957 |
| Financing Cash Flow | $-2,519,122 | $366,520 | $-4,859,410 | $-3,813,209 | $-2,022,098 |
| Exchange Rate Effect | -6,711 | 2,695 | -25,055 | 29,654 | -49,417 |
| Beginning Cash Position | 4,361,825 | 4,379,375 | 4,487,536 | 4,586,904 | 4,545,047 |
| End Cash Position | 3,951,142 | 4,310,652 | 4,229,071 | 3,718,856 | 4,439,534 |
| Net Cash Flow | $-410,683 | $-68,723 | $-258,465 | $-868,048 | $-105,512 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,141,585 | 1,537,498 | 10,208,060 | 7,363,578 | 4,328,680 |
| Capital Expenditure | -736,813 | -297,798 | -1,777,608 | -1,044,623 | -619,718 |
| Free Cash Flow | 4,404,772 | 1,239,701 | 8,430,452 | 6,318,955 | 3,708,962 |